121 related articles for article (PubMed ID: 37991725)
1. PRMT1 Inhibition Activates the Interferon Pathway to Potentiate Antitumor Immunity and Enhance Checkpoint Blockade Efficacy in Melanoma.
Tao H; Jin C; Zhou L; Deng Z; Li X; Dang W; Fan S; Li B; Ye F; Lu J; Kong X; Liu C; Luo C; Zhang Y
Cancer Res; 2024 Feb; 84(3):419-433. PubMed ID: 37991725
[TBL] [Abstract][Full Text] [Related]
2. PRMT1 acts as a suppressor of MHC-I and anti-tumor immunity.
Djajawi TM; Pijpers L; Srivaths A; Chisanga D; Chan KF; Hogg SJ; Neil L; Rivera SM; Bartonicek N; Ellis SL; Lim Kam Sian TCC; Faridi P; Liao Y; Pal B; Behren A; Shi W; Vervoort SJ; Johnstone RW; Kearney CJ
Cell Rep; 2024 Mar; 43(3):113831. PubMed ID: 38401121
[TBL] [Abstract][Full Text] [Related]
3. PRMT1-mediated H4R3me2a recruits SMARCA4 to promote colorectal cancer progression by enhancing EGFR signaling.
Yao B; Gui T; Zeng X; Deng Y; Wang Z; Wang Y; Yang D; Li Q; Xu P; Hu R; Li X; Chen B; Wang J; Zen K; Li H; Davis MJ; Herold MJ; Pan HF; Jiang ZW; Huang DCS; Liu M; Ju J; Zhao Q
Genome Med; 2021 Apr; 13(1):58. PubMed ID: 33853662
[TBL] [Abstract][Full Text] [Related]
4. PRMT1 is a novel molecular therapeutic target for clear cell renal cell carcinoma.
Wang J; Wang C; Xu P; Li X; Lu Y; Jin D; Yin X; Jiang H; Huang J; Xiong H; Ye F; Jin J; Chen Y; Xie Y; Chen Z; Ding H; Zhang H; Liu R; Jiang H; Chen K; Yao Z; Luo C; Huang Y; Zhang Y; Zhang J
Theranostics; 2021; 11(11):5387-5403. PubMed ID: 33859753
[No Abstract] [Full Text] [Related]
5. PRMT1 regulates tumor growth and metastasis of human melanoma via targeting ALCAM.
Li L; Zhang Z; Ma T; Huo R
Mol Med Rep; 2016 Jul; 14(1):521-8. PubMed ID: 27175582
[TBL] [Abstract][Full Text] [Related]
6. PRMT1-mediated arginine methylation of PIAS1 regulates STAT1 signaling.
Weber S; Maass F; Schuemann M; Krause E; Suske G; Bauer UM
Genes Dev; 2009 Jan; 23(1):118-32. PubMed ID: 19136629
[TBL] [Abstract][Full Text] [Related]
7. Methylation of C/EBPα by PRMT1 Inhibits Its Tumor-Suppressive Function in Breast Cancer.
Liu LM; Sun WZ; Fan XZ; Xu YL; Cheng MB; Zhang Y
Cancer Res; 2019 Jun; 79(11):2865-2877. PubMed ID: 31015230
[TBL] [Abstract][Full Text] [Related]
8. Protein arginine methyltransferase 1 modulates innate immune responses through regulation of peroxisome proliferator-activated receptor γ-dependent macrophage differentiation.
Tikhanovich I; Zhao J; Olson J; Adams A; Taylor R; Bridges B; Marshall L; Roberts B; Weinman SA
J Biol Chem; 2017 Apr; 292(17):6882-6894. PubMed ID: 28330868
[TBL] [Abstract][Full Text] [Related]
9. Intratumoral immunotherapy using a TLR2/3 agonist, L-pampo, induces robust antitumor immune responses and enhances immune checkpoint blockade.
Lee WS; Kim DS; Kim JH; Heo Y; Yang H; Go EJ; Kim JH; Lee SJ; Ahn BC; Yum JS; Chon HJ; Kim C
J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35764365
[TBL] [Abstract][Full Text] [Related]
10. Inhibiting Type I Arginine Methyltransferase Activity Promotes T Cell-Mediated Antitumor Immune Responses.
Fedoriw A; Shi L; O'Brien S; Smitheman KN; Wang Y; Hou J; Sherk C; Rajapurkar S; Laraio J; Williams LJ; Xu C; Han G; Feng Q; Bedford MT; Wang L; Barbash O; Kruger RG; Hwu P; Mohammad HP; Peng W
Cancer Immunol Res; 2022 Apr; 10(4):420-436. PubMed ID: 35181787
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of tumor intrinsic BANF1 activates antitumor immune responses via cGAS-STING and enhances the efficacy of PD-1 blockade.
Wang M; Huang Y; Chen M; Wang W; Wu F; Zhong T; Chen X; Wang F; Li Y; Yu J; Wu M; Chen D
J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37620043
[TBL] [Abstract][Full Text] [Related]
12. Wnt activation promotes memory T cell polyfunctionality via epigenetic regulator PRMT1.
Sung BY; Lin YH; Kong Q; Shah PD; Glick Bieler J; Palmer S; Weinhold KJ; Chang HR; Huang H; Avery RK; Schneck J; Chiu YL
J Clin Invest; 2022 Jan; 132(2):. PubMed ID: 35040433
[TBL] [Abstract][Full Text] [Related]
13. CD4
Xiao M; Xie L; Cao G; Lei S; Wang P; Wei Z; Luo Y; Fang J; Yang X; Huang Q; Xu L; Guo J; Wen S; Wang Z; Wu Q; Tang J; Wang L; Chen X; Chen C; Zhang Y; Yao W; Ye J; He R; Huang J; Ye L
J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35580929
[TBL] [Abstract][Full Text] [Related]
14. PRMT7 ablation stimulates anti-tumor immunity and sensitizes melanoma to immune checkpoint blockade.
Srour N; Villarreal OD; Hardikar S; Yu Z; Preston S; Miller WH; Szewczyk MM; Barsyte-Lovejoy D; Xu H; Chen T; Del Rincón SV; Richard S
Cell Rep; 2022 Mar; 38(13):110582. PubMed ID: 35354055
[TBL] [Abstract][Full Text] [Related]
15. The polymorphism rs975484 in the protein arginine methyltransferase 1 gene modulates expression of immune checkpoint genes in hepatocellular carcinoma.
Schonfeld M; Zhao J; Komatz A; Weinman SA; Tikhanovich I
J Biol Chem; 2020 May; 295(20):7126-7137. PubMed ID: 32245889
[TBL] [Abstract][Full Text] [Related]
16. Protein arginine methyltransferase 1 interacts with and activates p38α to facilitate erythroid differentiation.
Hua WK; Chang YI; Yao CL; Hwang SM; Chang CY; Lin WJ
PLoS One; 2013; 8(3):e56715. PubMed ID: 23483889
[TBL] [Abstract][Full Text] [Related]
17. PRMT1 arginine methyltransferase accumulates in cytoplasmic bodies that respond to selective inhibition and DNA damage.
Suchánková J; Legartová S; Sehnalová P; Kozubek S; Valente S; Labella D; Mai A; Eckerich C; Fackelmayer FO; Sorokin DV; Bartova E
Eur J Histochem; 2014 May; 58(2):2389. PubMed ID: 24998928
[TBL] [Abstract][Full Text] [Related]
18. Dynamics of human protein arginine methyltransferase 1(PRMT1) in vivo.
Herrmann F; Lee J; Bedford MT; Fackelmayer FO
J Biol Chem; 2005 Nov; 280(45):38005-10. PubMed ID: 16159886
[TBL] [Abstract][Full Text] [Related]
19. Combining protein arginine methyltransferase inhibitor and anti-programmed death-ligand-1 inhibits pancreatic cancer progression.
Zheng NN; Zhou M; Sun F; Huai MX; Zhang Y; Qu CY; Shen F; Xu LM
World J Gastroenterol; 2020 Jul; 26(26):3737-3749. PubMed ID: 32774054
[TBL] [Abstract][Full Text] [Related]
20. PRMT1 Is Recruited via DNA-PK to Chromatin Where It Sustains the Senescence-Associated Secretory Phenotype in Response to Cisplatin.
Musiani D; Giambruno R; Massignani E; Ippolito MR; Maniaci M; Jammula S; Manganaro D; Cuomo A; Nicosia L; Pasini D; Bonaldi T
Cell Rep; 2020 Jan; 30(4):1208-1222.e9. PubMed ID: 31995759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
